Article Details

Pfizer and Sangamo Therapeutics reopen recruitment for haemophilia A gene therapy trial

Retrieved on: 2022-09-26 11:46:23

Tags for this article:

Click the tags to see associated articles and topics

Pfizer and Sangamo Therapeutics reopen recruitment for haemophilia A gene therapy trial. View article details on HISWAI: https://www.pmlive.com/pharma_news/pfizer_and_sangamo_therapeutics_reopen_recruitment_for_haemophilia_a_gene_therapy_trial_1455918

Excerpt

Pfizer and Sangamo Therapeutics have reopened the recruitment of their phase 3 study evaluating giroctocogene fitelparvovec, an investigational ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up